If you liked this article you might like

Mylan's Weakness Shouldn't Last, So Buy Now
Allergan Cures Its Ailing Chart
Teva (TEVA) Stock Up, Allergen Deal Receives Clearance
Jim Cramer -- I Agree With the Analysts on Gap, Allergan